UMi038-A-1
General
Cell Line |
|
hPSCreg name | UMi038-A-1 |
Cite as: | UMi038-A-1 (RRID:CVCL_C0YZ) |
Cell line type | Human induced pluripotent stem cell (hiPSC) |
Similar lines |
|
Last update | 5th May 2022 |
User feedback | |
Provider |
|
Generator | University of Miami - Miller School of Medicine (UM) |
Owner | University of Miami - Miller School of Medicine (UM) |
Distributors | |
Derivation country | United States |
External Databases |
|
BioSamples | SAMEA14341487 |
Cellosaurus | CVCL_C0YZ |
Wikidata | Q114313199 |
General Information |
|
* Is the cell line readily obtainable for third parties? |
Yes Research use: allowed
Clinical use: not allowed
Commercial use: not allowed
|
Subclone of |
Donor Information
General Donor Information |
|
Sex | female |
Ethnicity | non-Hispanic White |
Phenotype and Disease related information (Donor) |
|
Diseases | A disease was diagnosed.
|
Family history | Yes |
Is the medical history available upon request? | no |
Is clinical information available? | yes |
Other Genotyping (Donor) |
|
Is there genome-wide genotyping or functional data available? |
No
|
Donor Relations |
|
Other cell lines of this donor | |
All cell lines of this donor's relatives |
Has sister:
|
External Databases (Donor) |
|
BioSamples | SAMEA14096005 |
Ethics
Also have a look at the ethics information for the parental line
UMi038-A
.
Is there an MTA available for the cell line? | No |
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used? | ThermoFisher SCientific |
Are you aware of any constraints on the use or distribution of the cell line from the owner or any parties identified in the query above? | No |
hIPSC Derivation
General |
|
The source cell information can be found in the parental cell line
UMi038-A.
|
|
Reprogramming method |
|
Vector type | Non-integrating |
Vector | Sendai virus |
Is reprogramming vector detectable? |
No |
Methods used |
PCR
|
Files and images showing reprogramming vector expressed or silenced | |
Vector free reprogramming |
|
Other |
|
Selection criteria for clones | Morphology |
Derived under xeno-free conditions |
No |
Derived under GMP? |
No |
Available as clinical grade? |
No |
Culture Conditions
Surface coating | Vitronectin |
Feeder cells |
No |
Passage method |
Enzymatically
Accutase
|
CO2 Concentration | 5 % |
Medium |
Other medium:
Base medium: StemFLEX(TM)
Main protein source: Serum concentration: 0 % |
Has Rock inhibitor (Y27632) been used at passage previously with this cell line? | Yes |
Has Rock inhibitor (Y27632) been used at cryo previously with this cell line? | No |
Has Rock inhibitor (Y27632) been used at thaw previously with this cell line? | No |
Characterisation
Analysis of Undifferentiated Cells
Marker | Expressed | Immunostaining | RT-PCR | Flow Cytometry | Enzymatic Assay | Expression Profiles |
Differentiation Potency
In vitro directed differentiation
Marker | Expressed |
SOX17 SRY-box transcription factor 17 |
Yes |
FOXA2 forkhead box A2 [ Homo sapiens (human) ] |
Yes |
In vitro directed differentiation
Marker | Expressed |
SMA: ACTA2 actin alpha 2, smooth muscle [ Homo sapiens (human) ] |
Yes |
TBXT T-box transcription factor T [ Homo sapiens (human) ] |
Yes |
In vitro directed differentiation
Marker | Expressed |
SOX1 SRY-box transcription factor 1 [ Homo sapiens (human) ] |
Yes |
PAX6 paired box 6 [ Homo sapiens (human) ] |
Yes |
Microbiology / Virus Screening |
|
Mycoplasma | Negative |
Genotyping
Karyotyping (Cell Line) |
|
Has the cell line karyotype been analysed? |
Yes
|
Other Genotyping (Cell Line) |
Genetic Modification
Disease/phenotype related modifications |
|
Login to share your feedback, experiences or results with the research community.